Beyond  the status quo 

At BioDigital Therapeutics, we're breaking the status quo in cancer research with AI. Our pioneering approach integrates artificial intelligence with cutting-edge genomics and medical imaging to redefine diagnostics and treatments. Join us in revolutionizing healthcare and ushering in a new era of personalized, precise medical solutions.

Beyond the status quo

At BioDigital Therapeutics, we're breaking the status quo in cancer research with AI. Our pioneering approach integrates artificial intelligence with cutting-edge genomics and medical imaging to redefine diagnostics and treatments. Join us in revolutionizing healthcare and ushering in a new era of personalized, precise medical solutions.

Areas of expertise

Driving excellence in specialized medical fields

AI for pacient profilingAI for therapies response predictionAI for medical imagingAI for drug designAI in genomic diagnosisAI for automated diagnosisAI in medical decission support systemsPatient telemonitoringScientific dissemination
Areas of expertise

Driving excellence in specialized medical fields

AI for pacient profilingAI for therapies response predictionAI for medical imagingAI for drug designAI in genomic diagnosisAI for automated diagnosisAI in medical decission support systemsPatient telemonitoringScientific dissemination
Join the Revolution in Healthcare

Transforming patient care with cutting-edge technology

Who is behind this project
We transform complex medical information into intuitive, accessible tools. By developing chatbots based on natural language processing, we enable instant, accurate access to clinical guidelines, technical data, and consensus documents. Our dual-purpose predictive models enhance patient stratification and treatment precision by forecasting clinical progression and identifying those likely to benefit from specific therapies. Complementing this, our advanced gene panel development and machine learning-driven medical image analysis provide precise diagnoses and uncover therapeutic targets, driving a more tailored and effective approach to cancer treatment.
digital twin-biodigital therapeutics
Digital Twins

The future of customized cancer treatment

The future of oncology lies in the creation of personalized digital twins for each patient, transforming how we understand and treat cancer. Our cutting-edge technologies and innovative approaches enable the development of these digital replicas, which simulate the unique characteristics and progression of an individual's cancer. By studying these digital twins, we can gain unprecedented insights into the behavior of the disease, allowing us to explore various therapeutic options in a virtual environment before applying them in real life.
This personalized model not only enhances our understanding of each patient’s specific cancer but also optimizes treatment processes. By testing and refining therapies on digital twins, we can identify the most effective strategies tailored to the individual, minimizing trial-and-error in clinical settings and reducing adverse effects. This revolutionary approach promises to elevate the precision and effectiveness of cancer treatments, paving the way for more successful patient outcomes and a new era in personalized oncology care.
Close sectionLearn more

About Us

Learn about BioDigital Therapeutics, our mission, vision and the partners driving innovation in cancer research and personalized medicine.

Discover Our Company

Our Services

Discover the range of services we offer, from AI-driven diagnostics to cutting-edge treatment solutions, designed to transform healthcare.

Explore Our Services

Our Technology

We leverage advanced AI to push the boundaries of medical science, developing groundbreaking therapies and diagnostic tools.

Uncover Our Tech

AI Solutions

At BioDigital Therapeutics, we support our specialized areas of expertise with cutting-edge software and innovative AI development.

Discover our products

Pioneering oncological therapies

In the ever-evolving field of oncology, the need for innovative therapies for hematological neoplasms is more pressing than ever. Traditional treatments often fall short, burdened by inefficacy and significant side effects. Our commitment is to overhaul this scenario by leveraging cutting-edge pharmaceutical development from inception through full validation. By doing so, we aim to not only create more effective treatments but also streamline the process, reducing both the time and financial burden associated with bringing new drugs to market.

Pioneering oncological therapies

In the ever-evolving field of oncology, the need for innovative therapies for hematological neoplasms is more pressing than ever. Traditional treatments often fall short, burdened by inefficacy and significant side effects. Our commitment is to overhaul this scenario by leveraging cutting-edge pharmaceutical development from inception through full validation. By doing so, we aim to not only create more effective treatments but also streamline the process, reducing both the time and financial burden associated with bringing new drugs to market.